FDA's Deborah Autor (’92) Finalist for Citizen Services Medal
Deborah Autor, '92, was recently named a finalist for the Citizen Services Medal based on her work as director of the Office of Compliance at the Center for Drug Evaluation and Research at the Food and Drug Administration (FDA).
Autor leads an initiative to remove from the market hundreds of potentially dangerous prescription medicines never approved for safety or effectiveness as required by law. She designed the program to identify unapproved drugs; evaluated the public health consequences; explored the legal challenges; set up incentive, education, and outreach programs; and initiated an aggressive enforcement effort.
So far, the FDA has taken enforcement actions to remove more than 500 unapproved prescription drugs from the market. Autor estimates that unapproved medicines represent less than 2 percent of prescriptions filled each year. However, in today’s multi-billion drug market, this means that thousands of consumers are exposed to potentially unsafe drugs every year.
“We are making significant strides in protecting the health of the American public,” she said.
Autor was a trial attorney for the Office of Consumer Litigation at the Justice Department before joining the FDA in 2002 as associate director of the Office of Compliance in the Center for Drug Evaluation and Research. She became its director in 2006.
The Service to America Medals are presented annually by the nonprofit, nonpartisan Partnership for Public Service to celebrate excellence in federal civic service. Autor is a finalist for the Citizen Services Medal, an award that recognizes a federal employee for a significant contribution to the nation in activities related to social services. Learn more about the awards here.
Read The Washington Post’s profile of Autor’s work here.
Reported by Elina Troshina